Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Photo: Brendan Smialowski/AFP via Getty Images
President Trump said on Wednesday that he plans to stop taking hydroxychloroquine as a defense against the novel coronavirus when his regimen finishes "in a day or two."
Why it matters: The FDA warned last month that the antimalarial drug appears to cause some serious and potentially life-threatening side effects in coronavirus patients.
Flashback: On Tuesday, when pressed on the FDA's warning, Trump responded by attacking a non-peer reviewed study that found an increased risk of death associated with patients who were only treated with the antimalarial drug — calling it a "false study."
- Trump said on Monday that he had been taking hydroxychloroquine for "about a week and a half."
Go deeper: Trump dismisses FDA warnings about hydroxychloroquine